As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading…
Reuters Health Information
Reuters Health Information
Analysis-Weight-loss Drug Forecasts Jump to $150 Billion as Supply Grows
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading...
Reuters Health Information
Reuters Health Information